Lorillard — Morgan Stanley Consumer & Retail Conference 2010
24 slides from Lorillard's conference presentation, Nov 16, 2010
Slide 1: Morgan Stanley Consumer & Retail Conference November 16, 2010
Morgan Stanley Consumer & Retail Conference November 16, 2010
Slide 2: Presenter Murray S. Kessler, President and CEO
Presenter Murray S. Kessler President and Chief Executive Officer
Slide 3: Safe Harbor Disclaimer
Safe Harbor Disclaimer You are cautioned that certain statements made in this presentation are "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation, any statement that may project, indicate or
Slide 4: Regulation G Compliance
Regulation G Compliance You are also reminded that during this presentation, certain non-GAAP financial measures, such as EBITDA and Adjusted Operating Income per 1,000 Cigarettes may be discussed. These measures should not be considered an alternative to net income, or any other measure of financia
Slide 5: Lorillard Overview - Who we are
Lorillard Overview - Who we are Third Largest Tobacco Company in the United States Spun-off from Loews Corporation in June 2008 2009 Net Sales - $5.2 B 2009 Operating Profit - $1.5 B 2009 Diluted EPS - $5.76 Current Dividend - $4.50/year Current Dividend - $4.50/year Current Dividend - $4.50/year Cu
Slide 6: Strong Brand Portfolio is Led by Newport
Menthol 28.8 71.2 Strong Brand Portfolio is Led by Newport Newport Others 91.5 8.5 Source: Domestic Shipment Data, Management Science Associates, Inc. #1 Menthol Brand in U.S 35% share of menthol market #2 Cigarette Brand in U.S. 10.4% share of market Primary Driver of Profitability Newport(r) Brand
Slide 7: Newport has Continued to Gain Share in a Category Segment That is Gaining Share
Newport has Continued to Gain Share... In a Category Segment That is Gaining Share 2004 2005 2006 2007 2008 2009 YTD Q3 2010 Newport 0.079 0.084 0.088 0.092 0.097 0.098 0.104 Other Menthol 0.185 0.183 0.186 0.187 0.187 0.19 0.191 26.4% 26.7% 27.4% 27.9% 28.4% 28.8% 29.5% Menthol Segment Share of Tot
Slide 8: Menthol Segment Is Gaining Share as it is less impacted by smokeless
Menthol Segment Is Gaining Share... As it is less impacted by cannibalization from smokeless tobacco Estimated Annual Volume Growth By Segment 2003-2010E Menthol Non- Menthol MST Male 99 117 195 Female 101 84 10 Large Metro 105 89 61 Non-Metro 90 133 217 Northeast 123 85 71 South 121 110 123 Midwest
Slide 9: With the Restage of Maverick, Lorillard has Profitably made progress in Discount
With the Restage of Maverick, Lorillard has also Profitably made progress in the Discount Segment Billions Of Units Maverick Unit Volume & Growth Rate 2004 2005 2006 2007 2008 2009 Maverick 0.7 0.9 1.1 1.4 2.3 3.5 +25.7% +23.4% +34.3% +60.5% +50.8% Maverick Unit Volume Up 33.9% Year to Date Q3 2010
Slide 10: Lorillard cigarette volume is growing while industry volume has declined
The combined result is that Lorillard cigarette volume is growing, while industry volume (non-menthol & menthol) has declined Billions Of Lorillard Units Billions Of Industry Units 5 Year CAGR 2010 YTD - -4.4% - -3.5% Industry 5 Year CAGR 2010 YTD +0.6% +5.5% Lorillard 2004 2005 2006 2007 2008 2009
Slide 11: Profitability of Lorillard vs. Competition
2004 2005 2006 2007 2008 2009 2010 9mos Lorillard 28.35 30.1 34.13 36.58 37.95 42.46 45.08 Philip Morris USA 23.72 25.02 26.29 28.07 29.74 35.7 40.22 Reynolds 13.26 16.45 17.41 20.12 23.01 24.87 27.46 Profitability of Lorillard vs. Competition Note: Based on Lorillard's analysis of competitors' publ
Slide 12: Lorillard is also aggressively buying back shares
$400 MM - Jul 2008 $250 MM - May 2009 $750 MM - Jul 2009 $250 MM - Feb 2010 $1 Billion - Aug 2010* * Authorized Lorillard is also aggressively buying back shares $2.65 Billion in Share Repurchases $3.68/year - Aug 2008 $4.00/year - Aug 2009 $4.50/year - Aug 2010 Dividend Increase of 22% since 2008 $
Slide 13: Lorillard has been Consistently Delivering Revenue and Profit Growth
2004 2005 2006 2007 2008 2009 Revenue 2.7 2.9 3.1 3.3 3.5 3.7 Net Sales* 2004 2005 2006 2007 2008 2009 Operating Income 1 1.1 1.2 1.3 1.4 1.5 Operating Income In Combination, Lorillard has been Consistently Delivering Revenue and Profit Growth $ Billions $ Billions 2004 2005 2006 2007 2008 2009 Net
Slide 14: By Most Measures, Lorillard has Beaten the Competition
By Most Measures, Lorillard has Beaten the Competition Revenue CAGR (2007-2009) 6.0% -1.9% -4.4% Unit Volume CAGR (2007-2009) -0.4% -7.8% -8.5% Market Share Change (2007-2009) +1.3 pts -1.9 pts -1.4 pts Adjusted Operating Margin (2009) 42% 37% 28% Adjusted Operating Income per 1,000 units (YTD Q3 20
Slide 15: Industry Week Ranked Lorillard the 2010 Best Manufacturing Company in America
Industry Week(r) Ranked Lorillard the 2010 "Best Manufacturing Company" in America "Best Manufacturing Company" in America "Best Manufacturing Company" in America Industry Week ranked the IW U.S. 500 Manufacturing Companies list based on three year revenue growth, return on equity, profit margin, as
Slide 16: 2010 Has Also Been a Solid Year
2010 Has Also Been a Solid Year Lorillard Market Share up +1.0 pts, Newport up +0.6 pts YTD Q3 2010 Quarter Ended 9/30/10 Change vs. Q3 2009 9 Months Ended 9/30/10 Change vs. 9 mos 2009 Total Unit Volume (in billions) 9.83 5.8% 28.13 5.5% Net Sales excluding FET ($ in millions) 1,073 12.6% 3,033 10.
Slide 17: Going Forward, Several Factors to Consider
Going Forward, Several Factors to Consider Pricing Environment Improved FDA Scientific Advisory Committee Recommendation FDA Decision on Menthol Newport(r) Non-Menthol Launch
Slide 18: Volume Trends have Returned to Pre-Federal Excise Tax Increase Levels
Volume Trends have Returned to Pre-Federal Excise Tax Increase Levels 3 Years Pre-FET Increase 12 Months Post-FET Increase 5 Months Post-Overlap Annual Percent Change Total Domestic Industry Unit Volume Changes Source: Domestic Shipment Data, Management Science Associates, Inc.
Slide 19: FDA Menthol Recommendation Update
FDA Menthol Recommendation Update TPSAC Recommendation due March 2011 - The beginning of the process... Lorillard strongly believes the overwhelming weight of scientific evidence shows that menthol cigarettes are not more dangerous than non-menthol cigarettes Key to TPSAC recommendation is whether i
Slide 20: Newport Non-Menthol Launch Makes Good Sense
Newport(r) Non-Menthol Launch Makes Good Sense Opportunity to grow Newport brand in remaining 70% of category Opportunity to grow Newport brand in remaining 70% of category
Slide 21: Lorillard is engaged in a Strategic Review focused on sustainable, profitable growth
Finally, Lorillard is engaged in a Strategic Review focused on sustainable, profitable growth over the long term Strategic Review Protect and Grow the Core Business Evaluate Capabilities & Process Explore Adjacency Expansion (i.e., non-menthol, smokeless) Results to be shared in 1H 2011
Slide 22: In Summary
In Summary A strong company with an excellent history of success Track record of delivering superior financial & operating results Second largest brand in industry - Newport(r) Operating model that is significantly more profitable than competition Focused on building shareholder value Five share buy
Slide 23: Questions
Questions Murray S. Kessler President and Chief Executive Officer David H. Taylor Executive Vice President and Chief Financial Officer
Slide 24: Appendix A Regulation G Reconciliations
Appendix A Regulation G Reconciliations ($ in millions) ($ in millions) Q3 9 months Period Ending Period Ending 2006 2007 2008 2009 2010 2010 Net Income Net Income $ 826 $ 898 $ 887 $ 948 $ 274 $ 770 Add: Income Taxes Add: Income Taxes 518 485 547 571 163 459 Other (Income) Expense, net Other (Incom
Lorillard — Morgan Stanley Consumer & Retail Conference 2010 on 6ix